Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Algoritmo alimentado con inteligencia artificial (IA) para predecir el paro cardíaco repentino (SCA) de un electrocardiograma (ECG)

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOUK20190905001
Publicado:
05/09/2019
Caducidad:
05/09/2020
Resumen:
Una empresa británica de software médico ha desarrollado un algoritmo alimentado con inteligencia artificial (IA) que predice el paro cardíaco repentino (SCA) con minutos de antelación y con gran precisión. El algoritmo puede servir de base para un sistema de alerta temprana que avise a los médicos de un parto cardíaco repentino inminente para mejorar la supervivencia. La empresa, que ha depositado varias patentes, busca socios corporativos con el fin de desarrollar nuevos productos de monitorización ECG o mejorar productos existentes. La cooperación se establecerá en el marco de un acuerdo de cooperación técnica o licencia.

Details

Tittle:
An artificial intelligence (AI) powered algorithm that predicts sudden cardiac arrest (SCA) from an electrocardiogram (ECG)
Summary:
A UK software company has developed an AI-powered algorithm that predicts sudden cardiac arrest minutes in advance with high accuracy. They are seeking corporate partners to create new or enhance existing ECG monitoring products, leveraging their AI. Type of co-operation sought: technical co-operation, license agreement.
Description:
A UK-based medical software company applies artificial intelligence to patient data to produce new early warning products. They are seeking to develop an early-warning system for sudden cardiac arrest (SCA). The company is seeking corporate partners to create a new or enhance an existing medical-grade ECG monitoring product.

Previous work resulted in the development of a prototype algorithm that predicts SCA. This algorithm could serve as the basis for an early warning system that could alert clinicians of impending SCA and improve survival.

They have filed several patents and published peer-reviewed articles. Their algorithm´s sophistication surpasses approaches in academic literature. They used a combination of cardiac datasets from hospital telemetry, Holter monitors, and implantable cardioverter defibrillators across the US, Europe and Asia. Their algorithm would trigger an alert before an arrest so that clinicians receive an opportunity to either identify and treat reversible triggers of arrhythmia, or prepare to defibrillate if the patient develops an arrest. In addition, early warning could usher in an era of research into the use of anti-arrhythmic medicines to prevent SCA.

Ideally, partners would have medical-grade ECG monitoring products on the market. The algorithm will enhance existing products or support the creation of new ones. The type of co-operation would be technical co-operation and transfer of the algorithm under license.
Advantages and Innovations:
No other technology warns patients ahead of an oncoming episode of sudden cardiac arrest. The technology does so with a real-time risk score that is highly performant on a time scale of minutes to an hour.
Stage of Development:
Available for demonstration
IPs:
Patent(s) applied for but not yet granted

Partner sought

Type and Role of Partner Sought:
Type of partner sought: industry.
Specific activity of partner sought: organisations with medical-grade ECG monitoring products.
Role of partner sought: the partner will license or co-develop the product.
Partners should be experienced in the healthcare field and have own products, such as device manufacturers. They should have capabilities for new product development.

Client

Type and Size of Client:
Industry SME <= 10
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English

Keywords

Technology Keywords:
06001011 Enfermedades circulatorias y del corazón
06001013 Tecnología médica / ingeniería biomédica